Global Neurovascular Devices Market Size & Outlook

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 34.96% in 2023. Horizon Databook has segmented the Global neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.

Increasing incidence of brain aneurysm globally is expected to impact the market growth positively in the forecast period. Brain aneurysm is also termed as intracranial or cerebral aneurysm, which is a bulge or ballooning in a blood vessel inside the brain. This aneurysm can rupture and cause bleeding in the adjacent subarachnoid space, thereby leading to a stroke or brain hemorrhage.

Neurovascular devices are mainly used to treat untreatable intracranial aneurysms and is placed in the parent artery, in order to divert blood flow. In addition, presence of large geriatric patient base is anticipated to be one of the key success factors for the market growth during the forecast period.

For instance, as per the Cleveland Clinic, up to 6% of people in the U.S. have an aneurysm in their brain with no bleeding (a condition of an unruptured aneurysm). In addition, approximately 10% to 30% of people who have a brain aneurysm deal with multiple aneurysms.